ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 130 filers reported holding ACCELERON PHARMA INC in Q1 2016. The put-call ratio across all filers is 3.66 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,224,000 | +241.2% | 140,000 | +133.3% | 1.44% | +57.4% |
| Q4 2016 | $1,531,000 | -39.6% | 60,000 | -14.3% | 0.92% | +102.4% |
| Q3 2016 | $2,534,000 | +49.1% | 70,000 | +40.0% | 0.45% | -34.6% |
| Q2 2016 | $1,699,000 | -14.1% | 50,000 | -33.3% | 0.69% | -4.7% |
| Q1 2016 | $1,979,000 | -72.9% | 75,000 | -50.0% | 0.72% | -69.9% |
| Q4 2015 | $7,314,000 | +167.0% | 150,000 | +36.4% | 2.41% | +123.5% |
| Q3 2015 | $2,739,000 | -42.3% | 110,000 | -26.7% | 1.08% | -28.1% |
| Q2 2015 | $4,746,000 | -28.7% | 150,000 | -14.3% | 1.50% | -46.6% |
| Q1 2015 | $6,661,000 | -28.8% | 175,000 | -27.1% | 2.80% | -38.0% |
| Q4 2014 | $9,350,000 | +1136.8% | 240,000 | +860.0% | 4.52% | +1018.6% |
| Q3 2014 | $756,000 | -79.8% | 25,000 | -77.3% | 0.40% | -76.8% |
| Q2 2014 | $3,737,000 | – | 110,000 | – | 1.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |